JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

BeOne Medicines Ltd ADR

Closed

SectorHealthcare

310.74 0.4

Overview

Share price change

24h

Current

Min

307.27

Max

312.8

Key metrics

By Trading Economics

Income

93M

94M

Sales

198M

1.3B

Profit margin

7.171

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+18.81% upside

Dividends

By Dow Jones

Next Earnings

6 Nov 2025

Market Stats

By TradingEconomics

Market Cap

22B

Previous open

310.34

Previous close

310.74

News Sentiment

By Acuity

50%

50%

145 / 371 Healthcare

BeOne Medicines Ltd ADR Chart

Past performance is not a reliable indicator of future results.

Related News

12 May 2025, 02:16 UTC

Major Market Movers

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

29 Jan 2025, 15:59 UTC

Major Market Movers

ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene

27 Nov 2024, 15:22 UTC

Major Market Movers

BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment

21 Nov 2024, 14:45 UTC

Major Market Movers

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

6 Aug 2025, 10:01 UTC

Earnings

BeOne Medicines Narrows FY25 View To Rev $5.0B-$5.3B >ONC

6 Aug 2025, 10:01 UTC

Earnings

BeOne Medicines 2Q Rev $1.3B >ONC

6 Aug 2025, 10:01 UTC

Earnings

BeOne Medicines 2Q Adj EPS $2.25 >ONC

6 Aug 2025, 10:00 UTC

Earnings

BeOne Medicines 2Q EPS 84c >ONC

9 Jul 2025, 09:17 UTC

Hot Stocks

Stocks to Watch Wednesday: Freeport-McMoRan, Glencore, Novo Nordisk -- WSJ

7 May 2025, 10:07 UTC

Earnings

BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC

7 May 2025, 10:06 UTC

Earnings

BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC

7 May 2025, 10:05 UTC

Earnings

BeiGene 1Q Net $1.27M >ONC

7 May 2025, 10:04 UTC

Earnings

BeiGene Says to Rename Company to BeOne Medicines >ONC

7 May 2025, 10:02 UTC

Earnings

BeiGene 1Q EPS $0.00 >ONC

7 May 2025, 10:02 UTC

Earnings

BeiGene 1Q Rev Increased 49% >ONC

7 May 2025, 10:00 UTC

Earnings

BeiGene 1Q Rev $1.12B >ONC

27 Feb 2025, 11:07 UTC

Earnings

BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Global BRUKINSA Rev of $828M >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Loss/Shr 11c >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Rev $1.13B >ONC

12 Nov 2024, 11:01 UTC

Earnings

BeiGene 3Q Loss/Shr 9c >BGNE

12 Nov 2024, 11:01 UTC

Earnings

BeiGene 3Q Rev $1B >BGNE

Peer Comparison

Price change

BeOne Medicines Ltd ADR Forecast

Price Target

By TipRanks

18.81% upside

12 Months Forecast

Average 368.34 USD  18.81%

High 399 USD

Low 345 USD

Based on 13 Wall Street analysts offering 12 month price targets forBeOne Medicines Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

12

Buy

1

Hold

0

Sell

Sentiment

By Acuity

145 / 371 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Operating profit

$

About BeOne Medicines Ltd ADR

BeiGene Ltd
help-icon Live chat